Index of artpub/2017/196392/

Crowley, Jeffrey
Long-term safety and tolerability of apremilast in patients with psoriasis : Pooled safety analysis for ≥156 weeks from 2 phase 3, randomized, controlled trials (ESTEEM 1 and 2)
2017
https://ddd.uab.cat/record/196392
[ICO]NameLast modifiedSizeDescription
[PARENTDIR]Parent Directory  -  
[ ]1=Crowley,_Jeffrey2022-06-29 13:32 17  
[ ]2=Long-term_safety_and_tolerability_of_apremilast...2022-06-29 13:32 180  
[ ]3=20172022-06-29 13:32 5  
[ ]4=1963922022-06-29 13:32 34  
[TXT]196392.dirinfo2025-02-07 02:59 317  
[ ]196392.du2025-02-07 02:59 49  
[TXT]196392.dupdirs2025-02-07 02:59 0  
[TXT]196392.dupfiles2025-02-07 02:59 0  
[TXT]196392.errors2025-02-07 02:59 0  
[TXT]196392.md52025-02-07 02:59 67  
[TXT]196392.sha12025-02-07 02:59 75  
[TXT]196392.sha2562025-02-07 02:59 99  
[TXT]196392.stats2025-02-07 02:59 246  
[IMG]jouameacader_a2017m8p310iENG.gif2019-03-11 14:01 40K 
[IMG]jouameacader_a2017m8p310iENG.ico2019-03-11 14:01 12K 
[TXT]jouameacader_a2017m8p310iENG.info2019-03-11 14:01 34K 
[ ]jouameacader_a2017m8p310iENG.pdf2019-03-11 14:01 310K 
[TXT]jouameacader_a2017m8p310iENG.txt2019-03-11 14:01 48K